Skip to main content

Norway patent prosecution process.

The patent prosecution process in Norway is as follows:

1. **Filing:** 

Submit a patent application to the Norwegian Industrial Property Office (NIPO). The application can be a national application, a regional (European) application designating Norway, or an international (PCT) application entering the national phase.

2. **Formal Examination:** 

NIPO conducts a formal examination to ensure the application meets all requirements, such as correct documentation and fees.

3. **Substantive Examination:** 

If requested, NIPO conducts a substantive examination to assess the patentability criteria, including novelty, inventive step, and industrial applicability.

4. **Publication:** 

If the application meets the requirements, it is published 18 months from the filing date or priority date.

5. **Third-Party Observations:** 

Third parties can submit observations on the patentability of the application within a certain timeframe after publication.

6. **Grant or Refusal:** 

If the application is found to meet all criteria, a patent is granted. If not, the applicant may have the opportunity to respond to objections or amend the application.

7. **Validation:** 

For European patents, the granted European patent must be validated in Norway by submitting a translation of the claims into Norwegian and paying a fee.

8. **Maintenance:** 

Annual renewal fees must be paid to keep the patent in force.


It's important to note that patent prosecution procedures can change, and it's advisable to refer to the latest information from NIPO or consult legal experts for the most up-to-date guidance.


For more topics on patent prosecution ,litigation :

Click 👉 e-Pharmatimes



Comments

Popular posts from this blog

Pharma Companies HR contact information

Dear viewers of my blog, I am happy to share the HR contact details of Pharmaceutical companies. Contact Details Of Pharma HRs : Zaydus cadila-Goa gajendravernekar@zayduscadila.com 09623458512/08326615143 Teva-Goa Maryann.Braganza@teva.co.in sanjay.pandit@teva.co.in 0832 6685538 Glenmark-Goa Vittal hebbalkar hr executivr - 9923476869 anupbannatti@glenmark-generics.com 09604151586 Watson-Goa Jyosna.bagule@watsonpharm.co.in runa.divkar@watsonpharm.co.in goa@watsonpharm.co.in 0832 6690666/777 Unichem Labs-Goa abhiram.panshikar@unichemlabs.com R&D  suraj.jadhav@unichemlabs.com vikas.parkar@unichemlabs.com Indico-Goa goahplc@Indoco.com varun.keny@indoco.com anand.ingole@Indoco.com 0832 6624109 Encube-Goa hr@encubeethicals.com nidhi.b@encubeethicals.com 8322392223 Torrent pharma-Ahmdabad mayurdesai@torrentpharma.com 9879603921/22/23/24 Emcure-pune RPKulkarni@emcure.co.in           Kishor.Mule@emcure.co.in Rahul.Morgaonkar@emcure.co.in recruitment@em

DoE - Doctrine of Equivalents

The Doctrine of Equivalents is a legal principle that is relevant to patent law, particularly in the United States, and it helps protect inventors' rights even when minor changes or substitutions have been made to a patented invention.  When an inventor applies for a patent, the claims in the patent document define the scope of protection for the invention. These claims outline the specific elements or features of the invention that are considered unique and non-obvious. If another party copies or uses the patented invention without permission, it may be considered infringement. However, in some cases, the accused infringer may make slight modifications to the invention that fall outside the literal scope of the patented claims. The Doctrine of Equivalents comes into play here. It allows the patent holder to assert that the accused infringer's modified version is still equivalent to the patented invention and, therefore, falls within the scope of the patent protection. For the

Competitive Landscape for Pharmaceutical Generic products.

Creating a competitive landscape for a pharmaceutical generic product involves analyzing the market and identifying key players, their strengths, weaknesses, and market positioning. Here's a simplified outline: **Competitive Landscape Analysis for Pharmaceutical Generic Product:** 1. **Market Overview:**    - Size of the pharmaceutical generic product market.    - Growth trends and forecasts.    - Regulatory environment and barriers to entry. 2. **Key Players:**    - List the major pharmaceutical companies producing the generic product.    - Include both global and regional players. 3. **Market Share:**    - Percentage of market share held by each major player.    - Trends in market share changes over time. 4. **Product Portfolio:**    - Types of generic products offered by each player.    - Variations in strengths, dosage forms, and delivery methods. 5. ** Competitive Advantage :**    - Identify unique selling points of each player's products.    - Cost advantages, manufacturi